Skip to content
PubMed This is a summary of 113 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 113 referenced papers

References

References (113)
  1. 1

    Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

    Finnerup NB, Attal N, Haroutounian S, et al.

    The Lancet. Neurology 2015; (14(2)):162-73.

    PMID: 25575710
  2. 2

    Sensory manifestations of diabetic neuropathies: anatomical and clinical correlations.

    Kazamel M, Dyck PJ

    Prosthetics and orthotics international 2015; (39(1)):7-16 doi:10.1177/0309364614536764.

    PMID: 25614497
  3. 3

    Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

    Balcıoğlu AS, Müderrisoğlu H

    World journal of diabetes 2015; (6(1)):80-91 doi:10.4239/wjd.v6.i1.80.

    PMID: 25685280
  4. 4

    A literature-based guide to the conservative and surgical management of the acute Charcot foot and ankle.

    Schade VL, Andersen CA

    Diabetic foot & ankle 2015; (6()):26627 doi:10.3402/dfa.v6.26627.

    PMID: 25795102
  5. 5

    Preventing and treating foot complications associated with diabetes mellitus.

    Bowling FL, Rashid ST, Boulton AJ

    Nature reviews. Endocrinology 2015; (11(10)):606-16 doi:10.1038/nrendo.2015.130.

    PMID: 26284447
  6. 6

    Microvascular complications and prevalence of urgency incontinence in Japanese patients with type 2 diabetes mellitus: The dogo study.

    Furukawa S, Sakai T, Niiya T, et al.

    Neurourology and urodynamics 2016; (35(8)):1024-1027 doi:10.1002/nau.22875.

    PMID: 26352009
  7. 7

    Distal Symmetric Polyneuropathy: A Review.

    Callaghan BC, Price RS, Feldman EL

    JAMA 2015; (314(20)):2172-81 doi:10.1001/jama.2015.13611.

    PMID: 26599185
  8. 8

    Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

    Javed S, Alam U, Malik RA

    The review of diabetic studies : RDS 2015; (12(1-2)):63-83 doi:10.1900/RDS.2015.12.63.

    PMID: 26676662
  9. 9

    Diabetic peripheral neuropathy may not be as its name suggests: evidence from magnetic resonance imaging.

    Tesfaye S, Selvarajah D, Gandhi R, et al.

    Pain 2016; (157 Suppl 1()):S72-S80 doi:10.1097/j.pain.0000000000000465.

    PMID: 26785159
  10. 10

    The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy.

    Parsons B, Li C

    Current medical research and opinion 2016; (32(5)):929-37 doi:10.1185/03007995.2016.1151776.

    PMID: 26854578
  11. 11

    The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.

    de León-Casasola OA, Mayoral V

    Journal of pain research 2016; (9()):67-79 doi:10.2147/JPR.S99231.

    PMID: 26929664
  12. 12

    Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities.

    Amin N, Doupis J

    World journal of diabetes 2016; (7(7)):153-64 doi:10.4239/wjd.v7.i7.153.

    PMID: 27076876
  13. 13

    Treating Painful Diabetic Peripheral Neuropathy: An Update.

    Snyder MJ, Gibbs LM, Lindsay TJ

    American family physician 2016; (94(3)):227-34.

    PMID: 27479625
  14. 14

    Entrapment neuropathies in diabetes mellitus.

    Rota E, Morelli N

    World journal of diabetes 2016; (7(17)):342-53 doi:10.4239/wjd.v7.i17.342.

    PMID: 27660694
  15. 15

    Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.

    Simpson DM, Robinson-Papp J, Van J, et al.

    The journal of pain 2017; (18(1)):42-53 doi:10.1016/j.jpain.2016.09.008.

    PMID: 27746370
  16. 16

    Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.

    Vinik AI, Perrot S, Vinik EJ, et al.

    BMC neurology 2016; (16(1)):251 doi:10.1186/s12883-016-0752-7.

    PMID: 27919222
  17. 17

    Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.

    Román-Pintos LM, Villegas-Rivera G, Rodríguez-Carrizalez AD, et al.

    Journal of diabetes research 2016; (2016()):3425617 doi:10.1155/2016/3425617.

    PMID: 28058263
  18. 18

    Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.

    Chaudhry HM, Mauermann ML, Rajkumar SV

    Mayo Clinic proceedings 2017; (92(5)):838-850 doi:10.1016/j.mayocp.2017.02.003.

    PMID: 28473042
  19. 19

    Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

    Wang F, Zhang J, Yu J, et al.

    Journal of diabetes research 2017; (2017()):8787261 doi:10.1155/2017/8787261.

    PMID: 29119118
  20. 20

    The Diabetic Foot Assessment.

    Johnson R, Osbourne A, Rispoli J, Verdin C

    Orthopedic nursing 2018; (37(1)):13-21 doi:10.1097/NOR.0000000000000414.

    PMID: 29369130
  21. 21

    One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.

    Binns-Hall O, Selvarajah D, Sanger D, et al.

    Diabetic medicine : a journal of the British Diabetic Association 2018; (35(7)):887-894 doi:10.1111/dme.13630.

    PMID: 29608799
  22. 22

    Charcot Foot: Clinical Clues, Diagnostic Strategies, and Treatment Principles.

    Marmolejo VS, Arnold JF, Ponticello M, Anderson CA

    American family physician 2018; (97(9)):594-599.

    PMID: 29763252
  23. 23

    Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.

    Schmidt BM, Holmes CM

    Current diabetes reports 2018; (18(10)):74 doi:10.1007/s11892-018-1047-8.

    PMID: 30112582
  24. 24

    The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial.

    Aan de Stegge WB, Mejaiti N, van Netten JJ, et al.

    Trials 2018; (19(1)):520 doi:10.1186/s13063-018-2890-2.

    PMID: 30249296
  25. 25

    Interleukin-10 Protects Schwann Cells against Advanced Glycation End Products-Induced Apoptosis via NF-κB Suppression.

    Xu S, Bao W, Men X, et al.

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2020; (128(2)):89-96 doi:10.1055/a-0826-4374.

    PMID: 30641609
  26. 26

    Management of diabetic foot ulcers in the community: an update.

    Levy N, Gillibrand W

    British journal of community nursing 2019; (24(Sup3)):S14-S19 doi:10.12968/bjcn.2019.24.Sup3.S14.

    PMID: 30817189
  27. 27

    The diabetic foot: Pathophysiology, evaluation, and treatment.

    Bandyk DF

    Seminars in vascular surgery 2018; (31(2-4)):43-48 doi:10.1053/j.semvascsurg.2019.02.001.

    PMID: 30876640
  28. 28

    SENSITIVITY OF FOUR SIMPLE METHODS TO SCREEN CHINESE PATIENTS FOR DIABETIC PERIPHERAL NEUROPATHY.

    Jie FY, Zafar MI, Xu L, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2018; (14(3)):410-415 doi:10.4183/aeb.2018.410.

    PMID: 31149292
  29. 29

    Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.

    Conte MS, Bradbury AW, Kolh P, et al.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2019; (58(1S)):S1-S109.e33 doi:10.1016/j.ejvs.2019.05.006.

    PMID: 31182334
  30. 30

    Diabetic neuropathy.

    Feldman EL, Callaghan BC, Pop-Busui R, et al.

    Nature reviews. Disease primers 2019; (5(1)):41 doi:10.1038/s41572-019-0092-1.

    PMID: 31197153
  31. 31

    Assessment of patient medication adherence among the type 2 diabetes mellitus population with peripheral diabetic neuropathy in South India.

    Samu AM, Amirthalingam PS, Mohammed OS

    Journal of Taibah University Medical Sciences 2017; (12(2)):164-168 doi:10.1016/j.jtumed.2016.12.006.

    PMID: 31435232
  32. 32

    Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.

    Hicks CW, Selvin E

    Current diabetes reports 2019; (19(10)):86 doi:10.1007/s11892-019-1212-8.

    PMID: 31456118
  33. 33

    Diabetic Foot Infection Presenting Systemic Inflammatory Response Syndrome: A Unique Disorder of Systemic Reaction from Infection of the Most Distal Body.

    Lin CW, Hung SY, Huang CH, et al.

    Journal of clinical medicine 2019; (8(10)) doi:10.3390/jcm8101538.

    PMID: 31557854
  34. 34

    A Clinician's Approach to Peripheral Neuropathy.

    Siao P, Kaku M

    Seminars in neurology 2019; (39(5)):519-530 doi:10.1055/s-0039-1694747.

    PMID: 31639835
  35. 35

    Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions.

    Himeno T, Kamiya H, Nakamura J

    Journal of diabetes investigation 2020; (11(1)):5-16 doi:10.1111/jdi.13173.

    PMID: 31677343
  36. 36

    Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes.

    Gylfadottir SS, Christensen DH, Nicolaisen SK, et al.

    Pain 2020; (161(3)):574-583 doi:10.1097/j.pain.0000000000001744.

    PMID: 31693539
  37. 37

    Diabetic neuropathy: A focus on small fibres.

    Malik RA

    Diabetes/metabolism research and reviews 2020; (36 Suppl 1()):e3255 doi:10.1002/dmrr.3255.

    PMID: 31828951
  38. 38

    Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis.

    Sun J, Wang Y, Zhang X, et al.

    Primary care diabetes 2020; (14(5)):435-444 doi:10.1016/j.pcd.2019.12.005.

    PMID: 31917119
  39. 39

    Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

    Braffett BH, Gubitosi-Klug RA, Albers JW, et al.

    Diabetes 2020; (69(5)):1000-1010 doi:10.2337/db19-1046.

    PMID: 32051148
  40. 40

    Treatment of diabetic peripheral neuropathy: a review.

    Khdour MR

    The Journal of pharmacy and pharmacology 2020; (72(7)):863-872 doi:10.1111/jphp.13241.

    PMID: 32067247
  41. 41

    Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus.

    Pafili K, Trypsianis G, Papazoglou D, et al.

    Diabetes therapy : research, treatment and education of diabetes and related disorders 2020; (11(4)):979-986 doi:10.1007/s13300-020-00795-0.

    PMID: 32172390
  42. 42

    Spectrum of diabetic neuropathies.

    Sasaki H, Kawamura N, Dyck PJ, et al.

    Diabetology international 2020; (11(2)):87-96 doi:10.1007/s13340-019-00424-7.

    PMID: 32206478
  43. 43

    Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.

    Moisset X, Bouhassira D, Avez Couturier J, et al.

    Revue neurologique 2020; (176(5)):325-352 doi:10.1016/j.neurol.2020.01.361.

    PMID: 32276788
  44. 44

    The effects of a supportive-educational intervention on women with type 2 diabetes and diabetic peripheral neuropathy: a randomized controlled trial.

    Ahrary Z, Khosravan S, Alami A, Najafi Nesheli M

    Clinical rehabilitation 2020; (34(6)):794-802 doi:10.1177/0269215520914067.

    PMID: 32306762
  45. 45

    Clinical insights into Charcot foot.

    Schmidt BM

    Best practice & research. Clinical rheumatology 2020; (34(3)):101563 doi:10.1016/j.berh.2020.101563.

    PMID: 32641254
  46. 46

    Clinical diagnosis and management of small fiber neuropathy: an update on best practice.

    Devigili G, Cazzato D, Lauria G

    Expert review of neurotherapeutics 2020; (20(9)):967-980 doi:10.1080/14737175.2020.1794825.

    PMID: 32654574
  47. 47

    Current concepts in the management of diabetic polyneuropathy.

    Ziegler D, Papanas N, Schnell O, et al.

    Journal of diabetes investigation 2021; (12(4)):464-475 doi:10.1111/jdi.13401.

    PMID: 32918837
  48. 48

    Determinants of Diabetic Foot Ulcer Among Adult Patients with Diabetes Attending the Diabetic Clinic in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: Unmatched Case-Control Study.

    Woldemariam GT, Atnafu NT, Radie YT, et al.

    Diabetes, metabolic syndrome and obesity : targets and therapy 2020; (13()):3739-3747 doi:10.2147/DMSO.S265988.

    PMID: 33116723
  49. 49

    Autonomic neuropathy and urologic complications in diabetes.

    Agochukwu-Mmonu N, Pop-Busui R, Wessells H, Sarma AV

    Autonomic neuroscience : basic & clinical 2020; (229()):102736 doi:10.1016/j.autneu.2020.102736.

    PMID: 33197694
  50. 50

    A Cross-Sectional Study on the Correlation Between Inflammatory Cytokines, Negative Emotions, and Onset of Peripheral Neuropathy in Type 2 Diabetes.

    Zheng YH, Ren CY, Shen Y, et al.

    Neuropsychiatric disease and treatment 2020; (16()):2881-2890 doi:10.2147/NDT.S278439.

    PMID: 33293813
  51. 51

    Blood-Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model.

    Takeshita Y, Sato R, Kanda T

    International journal of molecular sciences 2020; (22(1)) doi:10.3390/ijms22010062.

    PMID: 33374622
  52. 52

    [Multidisciplinary management of diabetic foot ulcer infection].

    Blanchette V, Brousseau-Foley M

    La Revue de medecine interne 2021; (42(3)):193-201 doi:10.1016/j.revmed.2020.09.004.

    PMID: 33451819
  53. 53

    Effects of novel diabetic therapeutic footwear on preventing ulcer recurrence in patients with a history of diabetic foot ulceration: study protocol for an open-label, randomized, controlled trial.

    Gao Y, Wang C, Chen D, et al.

    Trials 2021; (22(1)):151 doi:10.1186/s13063-021-05098-8.

    PMID: 33597005
  54. 54

    Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.

    Ponirakis G, Abdul-Ghani MA, Jayyousi A, et al.

    Journal of diabetes investigation 2021; (12(9)):1642-1650 doi:10.1111/jdi.13544.

    PMID: 33714226
  55. 55

    Intraepidermal Nerve Fiber Density as Measured by Skin Punch Biopsy as a Marker for Small Fiber Neuropathy: Application in Patients with Fibromyalgia.

    Kelley MA, Hackshaw KV

    Diagnostics (Basel, Switzerland) 2021; (11(3)) doi:10.3390/diagnostics11030536.

    PMID: 33802768
  56. 56

    Management of diabetic neuropathy.

    Cernea S, Raz I

    Metabolism: clinical and experimental 2021; (123()):154867 doi:10.1016/j.metabol.2021.154867.

    PMID: 34411554
  57. 57

    Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 years.

    Ziegler D, Bönhof GJ, Strom A, et al.

    Brain : a journal of neurology 2021; (144(10)):3251-3263 doi:10.1093/brain/awab330.

    PMID: 34499110
  58. 58

    Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review.

    Carvajal-Moreno L, Coheña-Jiménez M, García-Ventura I, et al.

    Journal of clinical medicine 2022; (11(6)) doi:10.3390/jcm11061723.

    PMID: 35330052
  59. 59

    Diabetic Foot Ulcer Among Adults Attending Follow-Up Diabetes Clinics in Wolaita Zone, Southern Ethiopia: An Unmatched, Case-Control Study.

    Gebrekirstos LG, Abadi MT, Gebremedhin MH, et al.

    Current therapeutic research, clinical and experimental 2022; (96()):100673 doi:10.1016/j.curtheres.2022.100673.

    PMID: 35601478
  60. 60

    Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review.

    D'Souza RS, Barman R, Joseph A, Abd-Elsayed A

    Current pain and headache reports 2022; (26(8)):583-594 doi:10.1007/s11916-022-01061-7.

    PMID: 35716275
  61. 61

    Diabetes: how to manage diabetic peripheral neuropathy.

    Gandhi M, Fargo E, Prasad-Reddy L, et al.

    Drugs in context 2022; (11()) doi:10.7573/dic.2021-10-2.

    PMID: 35775075
  62. 62

    Prevalence and determinants of silent myocardial ischemia in patients with type 2 diabetes in Cameroon: a cross-sectional study.

    Mfeukeu-Kuate L, Meyanui VA, Jingi AM, et al.

    The Pan African medical journal 2022; (42()):41 doi:10.11604/pamj.2022.42.41.34941.

    PMID: 35949456
  63. 63

    Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.

    Tesfaye S, Sloan G, Petrie J, et al.

    Lancet (London, England) 2022; (400(10353)):680-690 doi:10.1016/S0140-6736(22)01472-6.

    PMID: 36007534
  64. 64

    Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.

    Tesfaye S, Sloan G, Petrie J, et al.

    Health technology assessment (Winchester, England) 2022; (26(39)):1-100 doi:10.3310/RXUO6757.

    PMID: 36259684
  65. 65

    Preventing diabetes-related foot ulcers through early detection of peripheral neuropathy.

    McMorrow R, Nube VL, Manski-Nankervis JA

    Australian journal of general practice 2022; (51(11)):833-838 doi:10.31128/AJGP-06-22-6456.

    PMID: 36309996
  66. 66

    Influencing factors for the recurrence of diabetic foot ulcers: A meta-analysis.

    Guo Q, Ying G, Jing O, et al.

    International wound journal 2023; (20(5)):1762-1775 doi:10.1111/iwj.14017.

    PMID: 36385501
  67. 67

    Diabetic Amyotrophy (Bruns-Garland Syndrome): A Narrative Review.

    Agarwal A, Srivastava MVP, Vishnu VY

    Annals of Indian Academy of Neurology 2022; (25(5)):841-844 doi:10.4103/aian.aian_239_22.

    PMID: 36561022
  68. 68

    Diabetic peripheral neuropathy essentials: a narrative review.

    Chang MC, Yang S

    Annals of palliative medicine 2023; (12(2)):390-398 doi:10.21037/apm-22-693.

    PMID: 36786097
  69. 69

    Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options.

    Galiero R, Caturano A, Vetrano E, et al.

    International journal of molecular sciences 2023; (24(4)) doi:10.3390/ijms24043554.

    PMID: 36834971
  70. 70

    Development and validation of a risk prediction model for early diabetic peripheral neuropathy based on a systematic review and meta-analysis.

    Liu X, Chen D, Fu H, et al.

    Frontiers in public health 2023; (11()):1128069 doi:10.3389/fpubh.2023.1128069.

    PMID: 36908480
  71. 71

    Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials.

    Wu CS, Huang YJ, Ko YC, Lee CH

    Systematic reviews 2023; (12(1)):53 doi:10.1186/s13643-023-02185-6.

    PMID: 36945033
  72. 72

    Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy.

    Yang C, Zhao X, An X, et al.

    Frontiers in endocrinology 2023; (14()):1136796 doi:10.3389/fendo.2023.1136796.

    PMID: 37056668
  73. 73

    Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management.

    Preston FG, Riley DR, Azmi S, Alam U

    Diabetes, metabolic syndrome and obesity : targets and therapy 2023; (16()):1595-1612 doi:10.2147/DMSO.S370050.

    PMID: 37288250
  74. 74

    Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update).

    Bus SA, Sacco ICN, Monteiro-Soares M, et al.

    Diabetes/metabolism research and reviews 2024; (40(3)):e3651 doi:10.1002/dmrr.3651.

    PMID: 37302121
  75. 75

    Diabetic Foot Ulcers: A Review.

    Armstrong DG, Tan TW, Boulton AJM, Bus SA

    JAMA 2023; (330(1)):62-75 doi:10.1001/jama.2023.10578.

    PMID: 37395769
  76. 76

    Understanding the role of hyperglycemia and the molecular mechanism associated with diabetic neuropathy and possible therapeutic strategies.

    Kaur M, Misra S, Swarnkar P, et al.

    Biochemical pharmacology 2023; (215()):115723 doi:10.1016/j.bcp.2023.115723.

    PMID: 37536473
  77. 77

    The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer.

    Fitridge R, Chuter V, Mills J, et al.

    Diabetes/metabolism research and reviews 2024; (40(3)):e3686 doi:10.1002/dmrr.3686.

    PMID: 37726988
  78. 78

    An integrated personalized assistive devices approach to reduce the risk of foot ulcer recurrence in diabetes (DIASSIST): study protocol for a multicenter randomized controlled trial.

    Vossen LE, van Netten JJ, Bakker CD, et al.

    Trials 2023; (24(1)):663 doi:10.1186/s13063-023-07635-z.

    PMID: 37828618
  79. 79

    Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.

    Tsilingiris D, Schimpfle L, von Rauchhaupt E, et al.

    Diabetes 2024; (73(1)):135-146 doi:10.2337/db23-0271.

    PMID: 37862374
  80. 80

    Foot self-care practices among diabetic patients attending a teaching hospital in Tamil Nadu, India.

    Paramasivam S, Ramalingam G, Gani ARP

    Journal of family medicine and primary care 2023; (12(9)):2036-2041 doi:10.4103/jfmpc.jfmpc_409_23.

    PMID: 38024893
  81. 81

    Psychosocial Care for People With Diabetic Neuropathy: Time for Action.

    Pouwer F, Mizokami-Stout K, Reeves ND, et al.

    Diabetes care 2024; (47(1)):17-25 doi:10.2337/dci23-0033.

    PMID: 38117989
  82. 82

    Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study.

    Lai YR, Chiu WC, Huang CC, et al.

    Journal of diabetes investigation 2024; (15(3)):326-335 doi:10.1111/jdi.14131.

    PMID: 38168098
  83. 83

    Quality of life of persons with painful diabetic neuropathy: How can we improve it?

    Vileikyte L

    Diabetes research and clinical practice 2023; (206 Suppl 1()):110756 doi:10.1016/j.diabres.2023.110756.

    PMID: 38245321
  84. 84

    Conventional management and current guidelines for painful diabetic neuropathy.

    Tesfaye S, Kempler P

    Diabetes research and clinical practice 2023; (206 Suppl 1()):110765 doi:10.1016/j.diabres.2023.110765.

    PMID: 38245323
  85. 85

    Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment.

    Zhu J, Hu Z, Luo Y, et al.

    Frontiers in endocrinology 2023; (14()):1265372 doi:10.3389/fendo.2023.1265372.

    PMID: 38264279
  86. 86

    Diabetic Foot Infections in the Emergency Department.

    Frazee BW

    Emergency medicine clinics of North America 2024; (42(2)):267-285 doi:10.1016/j.emc.2024.01.003.

    PMID: 38641391
  87. 87

    Can the 128-Hz tuning fork be an alternative to the biothesiometer for diabetic peripheral neuropathy screening? A cross-sectional study in a tertiary hospital in East India.

    Chattopadhyay S, Goswami S, Sengupta N, Baidya A

    BMJ open 2024; (14(6)):e082193 doi:10.1136/bmjopen-2023-082193.

    PMID: 38862223
  88. 88

    Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach.

    Atmaca A, Ketenci A, Sahin I, et al.

    Frontiers in endocrinology 2024; (15()):1380929 doi:10.3389/fendo.2024.1380929.

    PMID: 38952393
  89. 89

    Advancing the Diagnosis of Diabetic Neuropathies: Electrodiagnostic and Skin Autofluorescence Methods.

    Trofin D, Salmen BM, Salmen T, et al.

    Journal of personalized medicine 2024; (14(8)) doi:10.3390/jpm14080884.

    PMID: 39202075
  90. 90

    The global and regional burden of diabetic peripheral neuropathy.

    Savelieff MG, Elafros MA, Viswanathan V, et al.

    Nature reviews. Neurology 2025; (21(1)):17-31 doi:10.1038/s41582-024-01041-y.

    PMID: 39639140
  91. 91

    Profiles of Peripheral Neuropathy and Risk Factors in People With Treatment-Naive Type 2 Diabetes Mellitus and Prediabetes.

    Mairaj MK, Pala NA, Ismail M

    Cureus 2024; (16(11)):e73304 doi:10.7759/cureus.73304.

    PMID: 39655103
  92. 92

    Diagnostic Accuracy of Screening Tests for Diabetic Peripheral Neuropathy: An Umbrella Review.

    Mogilevskaya M, Gaviria-Carrillo M, Feliciano-Alfonso JE, et al.

    Journal of diabetes research 2024; (2024()):5902036 doi:10.1155/jdr/5902036.

    PMID: 39664106
  93. 93

    Correlation Between Nitrous Oxide and Functional Vitamin B12 Deficiency Resulting in Subacute Combined Degeneration of the Spinal Cord: A Case Report.

    Kyaw KY, Lwin MT, Lwin ZT

    Cureus 2024; (16(11)):e74383 doi:10.7759/cureus.74383.

    PMID: 39723261
  94. 94

    Understanding the Impact of Diabetic Peripheral Neuropathy and Neuropathic Pain on Quality of Life and Mental Health in 6,960 People With Diabetes.

    Borbjerg MK, Wegeberg AM, Nikontovic A, et al.

    Diabetes care 2025; (48(4)):588-595 doi:10.2337/dc24-2287.

    PMID: 39932781
  95. 95

    Cytokine Signaling in Diabetic Neuropathy: A Key Player in Peripheral Nerve Damage.

    Nashtahosseini Z, Eslami M, Paraandavaji E, et al.

    Biomedicines 2025; (13(3)) doi:10.3390/biomedicines13030589.

    PMID: 40149566
  96. 96

    Improving Microcirculation With Nerve Decompression: The Missing Link in Treatment of Diabetic Neuropathy and Diabetic Foot Ulcer.

    Nickerson DS, Yamasaki DS

    International wound journal 2025; (22(4)):e70198 doi:10.1111/iwj.70198.

    PMID: 40234038
  97. 97

    Clinical Utility of Routine Monoclonal Gammopathy Testing in the Evaluation of Peripheral Neuropathy.

    Maberry MD, Smith CJ, Go RS

    Journal of general internal medicine 2026; (41(3)):753-758 doi:10.1007/s11606-025-09528-0.

    PMID: 40379937
  98. 98

    How Well do We Evaluate Small Fiber Neuropathy?: A Survey of American Academy of Neurology Members.

    Thawani S, Chan M, Ostendorf T, et al.

    Journal of clinical neuromuscular disease 2025; (26(4)):184-195 doi:10.1097/CND.0000000000000502.

    PMID: 40512966
  99. 99

    Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician.

    Lawson E, Singla P, Adler J, et al.

    Pain medicine (Malden, Mass.) 2026; (27(3)):279-316 doi:10.1093/pm/pnaf130.

    PMID: 41017645
  100. 100

    Diabetic Foot Screening: A Systematic Review of Global Guidelines and Questionnaire-Based Tools.

    Quak GSW, Lin JHX, Liew H, et al.

    The international journal of lower extremity wounds 2025; 15347346251381091 doi:10.1177/15347346251381091.

    PMID: 41021788
  101. 101

    Diabetic Neuropathy Part 2: Proximal and Asymmetric Phenotypes.

    Davalos L, Pasnoor M, Dimachkie MM, Barohn RJ

    Neurologic clinics 2025; (43(4)):693-710 doi:10.1016/j.ncl.2025.05.007.

    PMID: 41161991
  102. 102

    Diabetic distal symmetric polyneuropathy: More than just "tingling in the feet".

    Bell DSH, Jerkins TW

    Diabetes, obesity & metabolism 2026; (28(2)):817-825 doi:10.1111/dom.70235.

    PMID: 41198580
  103. 103

    Effect of Gabapentin on Heart Rate Variability in Patients with Painful Diabetic Peripheral Neuropathy: A Double-blinded Randomized Controlled Trial.

    Ahmadi F, Vasheghani M, Moradi M, et al.

    Iranian journal of pharmaceutical research : IJPR 2025; (24(1)):e165080 doi:10.5812/ijpr-165080.

    PMID: 41234388
  104. 104

    Autonomic neuropathy in diabetes.

    Tannus LRM, Cobas RA

    Archives of endocrinology and metabolism 2025; (70(special 1)):e250406 doi:10.20945/2359-4292-2025-0406.

    PMID: 41313194
  105. 105

    Early Diagnosis of Diabetic Neuropathy: A Review of Current Diagnostic Tests.

    Al-Khafaji M, Otti V

    Cureus 2025; (17(11)):e97880 doi:10.7759/cureus.97880.

    PMID: 41458830
  106. 106

    Targeting Oxidative Stress and Mitochondrial Dysfunction in Diabetic Neuropathy: Mechanisms and Therapeutic Opportunities.

    Sztanek F, Tóth LI, Hernyák M, et al.

    Antioxidants (Basel, Switzerland) 2026; (15(3)) doi:10.3390/antiox15030367.

    PMID: 41897513
  107. 107

    Sleep quality and diabetic neuropathy: A review and exploratory meta-analysis.

    Alsatam Alraoui O, Borbjerg MK, Klonoff DC, et al.

    Journal of diabetes and its complications 2026; (40(5)):109311 doi:10.1016/j.jdiacomp.2026.109311.

    PMID: 41905298
  108. 108

    Metformin-Associated Functional Vitamin B12 Deficiency Presenting as Subacute Combined Degeneration in a 57-Year-Old Man With Diabetes Mellitus.

    Zhang R, Gou L, Zhou X

    The American journal of case reports 2026; (27()):e952205 doi:10.12659/AJCR.952205.

    PMID: 42035456
  109. 109

    Effectiveness of Current Diagnostic Methods in the Early Detection of Diabetic Peripheral Neuropathy: Are We Missing the Window?

    Liaqat A

    Cureus 2026; (18(4)):e106429 doi:10.7759/cureus.106429.

    PMID: 42088795
  110. 110

    Temporal trends of selected diabetic foot deformities and risk factors: an exploratory analysis from a tertiary diabetes clinic.

    Štotl I, Blagus R, Urbančič-Rovan V

    Diabetes research and clinical practice 2026; (237()):113299 doi:10.1016/j.diabres.2026.113299.

    PMID: 42103114
  111. 111

    Bioenergetic failure in diabetic peripheral neuropathy: from glucotoxicity to multidimensional metabolic imbalance.

    Tao W, Yu Y, Wu X, et al.

    Journal of neurology 2026; (273(7)).

    PMID: 42342866
  112. 112

    Redox-Driven Blood-Nerve Barrier Dysfunction in Diabetic Peripheral Neuropathy: Mechanisms and Therapeutic Opportunities.

    Huang WH, Wong CS

    Antioxidants (Basel, Switzerland) 2026; (15(6)) doi:10.3390/antiox15060670.

    PMID: 42351976
  113. 113

    The pivotal role of immunometabolism in diabetic neuropathy and its potential therapeutic strategies.

    Lin R, Zhang X, Yang X, et al.

    Frontiers in endocrinology 2026; (17()):1791057 doi:10.3389/fendo.2026.1791057.

    PMID: 42369056